North America

SVB provides venture debt to Parity

Parity Inc has secured C$1.25 million in venture debt from Silicon Valley Bank. Parity is a Canadian protech company using artificial intelligence to eliminate energy waste in multi-residential buildings. Recently, Parity closed a Series A investment with ArcTern Ventures, a North American cleantech venture fund.

Relentless Venture Fund invests in Snapclarity

The Relentless Venture Fund has made an investment in Ottawa-based Snapclarity Inc, a mental well-being and healthcare platform. No financial terms were disclosed. In addition to the funding, Brenda Irwin will be joining Snapclarity's board of directors.

Octopus Ventures leads $5.5 mln round for vHive

vHive, a provider of software solutions that enables enterprises to deploy autonomous drone hives to digitize their field assets and operations, has secured $5.5 million in funding. Octopus Ventures led the round with participation from other investors that included StageOne Ventures. In addition to the funding, Zoe Chambers of Octopus Ventures has joined the vHive's board of directors.

Data science platform Explorium nabs $19 mln

San Francisco and Tel Aviv-based Explorium, a data science platform, has secured $19 million in funding. The investors included Emerge, F2 Capital and Zeev Ventures.

Redefine Meat rakes in $6 mln seed

Redefine Meat, a creator of animal-free meat using proprietary industrial 3D printers, has raised $6 million in seed funding. CPT Capital led the round with participation from other investors that included Hanaco Ventures and The PHW Group.

Echodyne scores $20 mln

Echodyne, a maker of high-performance radars for government and commercial markets, has secured $20 million in financing. The investors included Bill Gates, Madrona Ventures, NEA, Vulcan Capital, Lux Capital and Vanedge Capital.

GSK to acquire Sitari

GlaxoSmithKline has agreed to acquire Sitari Pharmaceuticals, a developer of a treatment for celiac disease. No financial terms were disclosed. Sitari was incubated at COI Pharmaceuticals, which was established by Avalon Ventures.

Swiss biotech firm Anokion grabs $40 mln

Anokion SA, a Swiss biotechnology company, has secured $40 million in funding. The investors included Versant Ventures, Novartis Venture Fund, Novo Ventures and Celgene. Also, Anokon has acquired Kanyos Bio Inc. No financial terms were disclosed.

Angelo Gordon racks up $1.3 bln for fourth Asia real estate fund

Angelo Gordon has raised $1.3 billion for its fourth Asia real estate fund, beating its $1 billion target. The firm closed its previous Asia real estate fund at about $850 million in 2016.

JobTeaser inks funding

Paris-based JobTeaser, an online graduate recruiter, has secured 45 million pounds in funding. Highland Europe led the round with participation from Alven, Idinvest Partners, Seventure Partners and Korelya Capital.